1. Home
  2. FOXX vs COEP Comparison

FOXX vs COEP Comparison

Compare FOXX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXX
  • COEP
  • Stock Information
  • Founded
  • FOXX 2017
  • COEP 2017
  • Country
  • FOXX United States
  • COEP United States
  • Employees
  • FOXX N/A
  • COEP N/A
  • Industry
  • FOXX
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FOXX
  • COEP Health Care
  • Exchange
  • FOXX Nasdaq
  • COEP Nasdaq
  • Market Cap
  • FOXX 33.5M
  • COEP 30.5M
  • IPO Year
  • FOXX N/A
  • COEP N/A
  • Fundamental
  • Price
  • FOXX $5.32
  • COEP $12.24
  • Analyst Decision
  • FOXX
  • COEP
  • Analyst Count
  • FOXX 0
  • COEP 0
  • Target Price
  • FOXX N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • FOXX 13.4K
  • COEP 25.5K
  • Earning Date
  • FOXX 05-15-2025
  • COEP 05-09-2025
  • Dividend Yield
  • FOXX N/A
  • COEP N/A
  • EPS Growth
  • FOXX N/A
  • COEP N/A
  • EPS
  • FOXX N/A
  • COEP N/A
  • Revenue
  • FOXX $42,988,015.00
  • COEP N/A
  • Revenue This Year
  • FOXX N/A
  • COEP N/A
  • Revenue Next Year
  • FOXX N/A
  • COEP N/A
  • P/E Ratio
  • FOXX N/A
  • COEP N/A
  • Revenue Growth
  • FOXX 98.81
  • COEP N/A
  • 52 Week Low
  • FOXX $2.45
  • COEP $2.31
  • 52 Week High
  • FOXX $14.99
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • FOXX N/A
  • COEP 69.07
  • Support Level
  • FOXX N/A
  • COEP $9.16
  • Resistance Level
  • FOXX N/A
  • COEP $11.69
  • Average True Range (ATR)
  • FOXX 0.00
  • COEP 0.48
  • MACD
  • FOXX 0.00
  • COEP 0.30
  • Stochastic Oscillator
  • FOXX 0.00
  • COEP 96.64

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: